-
1
-
-
0003339017
-
A phase I pharmacokinetic/pharmacodynamic study evaluating multiple doses of oral GW572016 in healthy subjects
-
(Abstract 374)
-
Adams V.R., Bence A.K., Anderson E.B., Halepota M.A., Smith D.A., Koch K.M., Bowen C.J., Mangum S.G., Spector N.L., Davis G.A., Doukas M.A., DeSimone P.A. A phase I pharmacokinetic/pharmacodynamic study evaluating multiple doses of oral GW572016 in healthy subjects. Proc Am Soc Clin Oncol. 21:2002;94a. (Abstract 374).
-
(2002)
Proc Am Soc Clin Oncol
, vol.21
-
-
Adams, V.R.1
Bence, A.K.2
Anderson, E.B.3
Halepota, M.A.4
Smith, D.A.5
Koch, K.M.6
Bowen, C.J.7
Mangum, S.G.8
Spector, N.L.9
Davis, G.A.10
Doukas, M.A.11
Desimone, P.A.12
-
2
-
-
0036269883
-
ErbB2 is required for muscle spindle and myoblast cell survival
-
Andrechek E.R., Hardy W.R., Girgis-Gabardo A.A., Perry R.L., Butler R., Graham F.L., Kahn R.C., Rudnicki M.A., Muller W.J. ErbB2 is required for muscle spindle and myoblast cell survival. Mol Cell Biol. 22(13):2002;4714-4722.
-
(2002)
Mol Cell Biol
, vol.22
, Issue.13
, pp. 4714-4722
-
-
Andrechek, E.R.1
Hardy, W.R.2
Girgis-Gabardo, A.A.3
Perry, R.L.4
Butler, R.5
Graham, F.L.6
Kahn, R.C.7
Rudnicki, M.A.8
Muller, W.J.9
-
3
-
-
0032579405
-
Constitutive activation of c-Jun N-terminal kinase by a mutant epidermal growth factor receptor
-
Antonyak M.A., Moscatello D.K., Wong A.J. Constitutive activation of c-Jun N-terminal kinase by a mutant epidermal growth factor receptor. J Biol Chem. 273(5):1998;2817-2822.
-
(1998)
J Biol Chem
, vol.273
, Issue.5
, pp. 2817-2822
-
-
Antonyak, M.A.1
Moscatello, D.K.2
Wong, A.J.3
-
4
-
-
0025605344
-
The let-23 gene necessary for Caenorhabditis elegans vulval induction encodes a tyrosine kinase of the EGF receptor subfamily
-
Aroian R.V., Koga M., Mendel J.E., Ohshima Y., Sternberg P.W. The let-23 gene necessary for Caenorhabditis elegans vulval induction encodes a tyrosine kinase of the EGF receptor subfamily. Nature. 348(6303):1990;693-699.
-
(1990)
Nature
, vol.348
, Issue.6303
, pp. 693-699
-
-
Aroian, R.V.1
Koga, M.2
Mendel, J.E.3
Ohshima, Y.4
Sternberg, P.W.5
-
5
-
-
18544380391
-
Deranged expression of the E-cadherin/beta-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas
-
Bankfalvi A., Krassort M., Vegh A., Felszeghy E., Piffko J. Deranged expression of the E-cadherin/beta-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas. J Oral Pathol Med. 31(8):2002;450-457.
-
(2002)
J Oral Pathol Med
, vol.31
, Issue.8
, pp. 450-457
-
-
Bankfalvi, A.1
Krassort, M.2
Vegh, A.3
Felszeghy, E.4
Piffko, J.5
-
6
-
-
9044251203
-
The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer
-
Bartlett J.M., Langdon S.P., Simpson B.J., Stewart M., Katsaros D., Sismondi P., Love S., Scott W.N., Williams A.R., Lessells A.M., Macleod K.G., Smyth J.F., Miller W.R. The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer. Br J Cancer. 73(3):1996;301-306.
-
(1996)
Br J Cancer
, vol.73
, Issue.3
, pp. 301-306
-
-
Bartlett, J.M.1
Langdon, S.P.2
Simpson, B.J.3
Stewart, M.4
Katsaros, D.5
Sismondi, P.6
Love, S.7
Scott, W.N.8
Williams, A.R.9
Lessells, A.M.10
MacLeod, K.G.11
Smyth, J.F.12
Miller, W.R.13
-
7
-
-
0036362181
-
Why the epidermal growth factor receptor? the rationale for cancer therapy
-
Baselga J. Why the epidermal growth factor receptor? The rationale for cancer therapy. Oncologist. 7(Suppl. 4):2002;2-8.
-
(2002)
Oncologist
, vol.7
, Issue.SUPPL. 4
, pp. 2-8
-
-
Baselga, J.1
-
8
-
-
0028863853
-
Epidermal growth factor ligand-independent, unregulated, cell-transforming potential of a naturally occurring human mutant EGFRvIII gene
-
Batra S.K., Castelino-Prabhu S., Wikstrand C.J., Zhu X., Humphrey P.A., Friedman H.S., Bigner D.D. Epidermal growth factor ligand-independent, unregulated, cell-transforming potential of a naturally occurring human mutant EGFRvIII gene. Cell Growth Differ. 6(10):1995;1251-1259.
-
(1995)
Cell Growth Differ
, vol.6
, Issue.10
, pp. 1251-1259
-
-
Batra, S.K.1
Castelino-Prabhu, S.2
Wikstrand, C.J.3
Zhu, X.4
Humphrey, P.A.5
Friedman, H.S.6
Bigner, D.D.7
-
9
-
-
0035001584
-
Clinical trial with escalating doses of the antiepidermal growth factor receptor humanized monoclonal antibody EMD 72 000 in patients with advanced squamous cell carcinoma of the larynx and hypopharynx
-
Bier H., Hoffmann T., Hauser U., Wink M., Ochler M., Kovar A., Muser M., Knecht R. Clinical trial with escalating doses of the antiepidermal growth factor receptor humanized monoclonal antibody EMD 72. 000 in patients with advanced squamous cell carcinoma of the larynx and hypopharynx Cancer Chemother Pharmacol. 47(6):2001;519-524.
-
(2001)
Cancer Chemother Pharmacol
, vol.47
, Issue.6
, pp. 519-524
-
-
Bier, H.1
Hoffmann, T.2
Hauser, U.3
Wink, M.4
Ochler, M.5
Kovar, A.6
Muser, M.7
Knecht, R.8
-
10
-
-
0032525784
-
The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system
-
Britsch S., Li L., Kirchhoff S., Theuring F., Brinkmann V., Birchmeier C., Riethmacher D. The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system. Genes Dev. 12(12):1998;1825-1836.
-
(1998)
Genes Dev
, vol.12
, Issue.12
, pp. 1825-1836
-
-
Britsch, S.1
Li, L.2
Kirchhoff, S.3
Theuring, F.4
Brinkmann, V.5
Birchmeier, C.6
Riethmacher, D.7
-
11
-
-
0031048942
-
EGF-R expression in ductal breast cancer: Proliferation and prognostic implications
-
Bucci B., D'Agnano I., Botti C., Mottolese M., Carico E., Zupi G., Vecchione A. EGF-R expression in ductal breast cancer: proliferation and prognostic implications. Anticancer Res. 17(1B):1997;769-774.
-
(1997)
Anticancer Res
, vol.17
, Issue.1 B
, pp. 769-774
-
-
Bucci, B.1
D'Agnano, I.2
Botti, C.3
Mottolese, M.4
Carico, E.5
Zupi, G.6
Vecchione, A.7
-
12
-
-
0036554816
-
Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention
-
Buettner R., Mora L.B., Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res. 8(4):2002;945-954.
-
(2002)
Clin Cancer Res
, vol.8
, Issue.4
, pp. 945-954
-
-
Buettner, R.1
Mora, L.B.2
Jove, R.3
-
13
-
-
0032894071
-
The expression of type I growth factor receptors in the squamous neoplastic changes of uterine cervix
-
Chang J.L., Tsao Y.P., Liu D.W., Han C.P., Lee W.H., Chen S.L. The expression of type I growth factor receptors in the squamous neoplastic changes of uterine cervix. Gynecol Oncol. 73(1):1999;62-71.
-
(1999)
Gynecol Oncol
, vol.73
, Issue.1
, pp. 62-71
-
-
Chang, J.L.1
Tsao, Y.P.2
Liu, D.W.3
Han, C.P.4
Lee, W.H.5
Chen, S.L.6
-
14
-
-
0030980531
-
Significance of urinary epidermal growth factor and its receptor expression in human bladder cancer
-
Chow N.H., Liu H.S., Lee E.I., Chang C.J., Chan S.H., Cheng H.L., Tzai T.S., Lin J.S. Significance of urinary epidermal growth factor and its receptor expression in human bladder cancer. Anticancer Res. 17(2B):1997;1293-1296.
-
(1997)
Anticancer Res
, vol.17
, Issue.2 B
, pp. 1293-1296
-
-
Chow, N.H.1
Liu, H.S.2
Lee, E.I.3
Chang, C.J.4
Chan, S.H.5
Cheng, H.L.6
Tzai, T.S.7
Lin, J.S.8
-
15
-
-
0037302445
-
Epidermal growth factor receptor as a therapeutic target in colorectal cancer
-
Cohen R.B. Epidermal growth factor receptor as a therapeutic target in colorectal cancer. Clin Colorectal Cancer. 2(4):2003;246-251.
-
(2003)
Clin Colorectal Cancer
, vol.2
, Issue.4
, pp. 246-251
-
-
Cohen, R.B.1
-
16
-
-
0001303067
-
Phase II study of ZD1839 (Iressa) in recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN)
-
(899)
-
Cohen E., Rosen F., Dekker A.et al. Phase II study of ZD1839 (Iressa) in recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Proc Am Soc Clin Oncol. 21:2002;225a. (899).
-
(2002)
Proc Am Soc Clin Oncol
, vol.21
-
-
Cohen, E.1
Rosen, F.2
Dekker, A.3
-
17
-
-
0037336316
-
Pharmacological evaluation of humanized anti-epidermal growth factor receptor, monoclonal antibody h-R3, in patients with advanced epithelial-derived cancer
-
Crombet T., Torres L., Neninger E., Catala M., Solano M.E., Perera A., Torres O., Iznaga N., Torres F., Perez R., Lage A. Pharmacological evaluation of humanized anti-epidermal growth factor receptor, monoclonal antibody h-R3, in patients with advanced epithelial-derived cancer. J Immunother. 26(2):2003;139-148.
-
(2003)
J Immunother
, vol.26
, Issue.2
, pp. 139-148
-
-
Crombet, T.1
Torres, L.2
Neninger, E.3
Catala, M.4
Solano, M.E.5
Perera, A.6
Torres, O.7
Iznaga, N.8
Torres, F.9
Perez, R.10
Lage, A.11
-
18
-
-
0030727901
-
Clinical experience with CD64-directed immunotherapy. An overview
-
Curnow R.T. Clinical experience with CD64-directed immunotherapy. An overview. Cancer Immunol Immunother. 45(3-4):1997;210-215.
-
(1997)
Cancer Immunol Immunother
, vol.45
, Issue.34
, pp. 210-215
-
-
Curnow, R.T.1
-
19
-
-
0036132083
-
Epidermal growth factor receptor mutation type III transfected into a small cell lung cancer cell line is predominantly localized at the cell surface and enhances the malignant phenotype
-
Damstrup L., Wandahl Pedersen M., Bastholm L., Elling F., Skovgaard Poulsen H. Epidermal growth factor receptor mutation type III transfected into a small cell lung cancer cell line is predominantly localized at the cell surface and enhances the malignant phenotype. Int J Cancer. 97(1):2002;7-14.
-
(2002)
Int J Cancer
, vol.97
, Issue.1
, pp. 7-14
-
-
Damstrup, L.1
Wandahl Pedersen, M.2
Bastholm, L.3
Elling, F.4
Skovgaard Poulsen, H.5
-
20
-
-
0030683639
-
Signal characteristics of G protein-transactivated EGF receptor
-
Daub H., Wallasch C., Lankenau A., Herrlich A., Ullrich A. Signal characteristics of G protein-transactivated EGF receptor. EMBO J. 16(23):1997;7032-7044.
-
(1997)
EMBO J
, vol.16
, Issue.23
, pp. 7032-7044
-
-
Daub, H.1
Wallasch, C.2
Lankenau, A.3
Herrlich, A.4
Ullrich, A.5
-
21
-
-
0003266310
-
A phase I study to investigate the safety, tolerability, and pharmacokinetics of single oral escalating doses of GW572016 in healthy volunteers
-
(Abstract 375)
-
DeSimone P.A., Bence A.K., Anderson E.B., Halepota M.A., Smith D.A., Koch K.M., Stead A.G., Mangum S.G., Spector N.L., Davis G.A., Doukas M.A., Adams V.R. A phase I study to investigate the safety, tolerability, and pharmacokinetics of single oral escalating doses of GW572016 in healthy volunteers. Proc Am Soc Clin Oncol. 21:2002;94a. (Abstract 375).
-
(2002)
Proc Am Soc Clin Oncol
, vol.21
-
-
Desimone, P.A.1
Bence, A.K.2
Anderson, E.B.3
Halepota, M.A.4
Smith, D.A.5
Koch, K.M.6
Stead, A.G.7
Mangum, S.G.8
Spector, N.L.9
Davis, G.A.10
Doukas, M.A.11
Adams, V.R.12
-
22
-
-
0001100601
-
A phase I and pharmacological study of PKI166, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, administered orally 3 times a week to patients with advanced cancer
-
(Abstract 341)
-
Dumez H., Hoekstra R., Eskens F., Sizer K.C., Vaidyanathan S., Ravera C., van Oosterom A.T., Verweij J., Gasthuisberg U.Z. A phase I and pharmacological study of PKI166, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, administered orally 3 times a week to patients with advanced cancer. Proc Am Soc Clin Oncol. 2002;. (Abstract 341).
-
(2002)
Proc Am Soc Clin Oncol
-
-
Dumez, H.1
Hoekstra, R.2
Eskens, F.3
Sizer, K.C.4
Vaidyanathan, S.5
Ravera, C.6
Van Oosterom, A.T.7
Verweij, J.8
Gasthuisberg, U.Z.9
-
23
-
-
0025790916
-
Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo
-
Ekstrand A.J., James C.D., Cavenee W.K., Seliger B., Pettersson R.F., Collins V.P. Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res. 51(8):1991;2164-2172.
-
(1991)
Cancer Res
, vol.51
, Issue.8
, pp. 2164-2172
-
-
Ekstrand, A.J.1
James, C.D.2
Cavenee, W.K.3
Seliger, B.4
Pettersson, R.F.5
Collins, V.P.6
-
24
-
-
0033671412
-
TGF-alpha antisense gene therapy inhibits head and neck squamous cell carcinoma growth in vivo
-
[in process citation]
-
Endo S., Zeng Q., Burke N.A., He Y., Melhem M.F., Watkins S.F., Lango M.N., Drenning S.D., Huang L., Rubin Grandis J. TGF-alpha antisense gene therapy inhibits head and neck squamous cell carcinoma growth in vivo. [in process citation] Gene Ther. 7(22):2000;1906-1914.
-
(2000)
Gene Ther
, vol.7
, Issue.22
, pp. 1906-1914
-
-
Endo, S.1
Zeng, Q.2
Burke, N.A.3
He, Y.4
Melhem, M.F.5
Watkins, S.F.6
Lango, M.N.7
Drenning, S.D.8
Huang, L.9
Rubin Grandis, J.10
-
25
-
-
0031454062
-
ErbB3 is required for normal cerebellar and cardiac development: A comparison with ErbB2- and heregulin-deficient mice
-
Erickson S.L., O'Shea K.S., Ghaboosi N., Loverro L., Frantz G., Bauer M., Lu L.H., Moore M.W. ErbB3 is required for normal cerebellar and cardiac development: A comparison with ErbB2- and heregulin-deficient mice. Development. 124(24):1997;4999-5011.
-
(1997)
Development
, vol.124
, Issue.24
, pp. 4999-5011
-
-
Erickson, S.L.1
O'Shea, K.S.2
Ghaboosi, N.3
Loverro, L.4
Frantz, G.5
Bauer, M.6
Lu, L.H.7
Moore, M.W.8
-
26
-
-
0032763824
-
Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens
-
Feldkamp M.M., Lala P., Lau N., Roncari L., Guha A. Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens. Neurosurgery. 45(6):1999;1442-1453.
-
(1999)
Neurosurgery
, vol.45
, Issue.6
, pp. 1442-1453
-
-
Feldkamp, M.M.1
Lala, P.2
Lau, N.3
Roncari, L.4
Guha, A.5
-
27
-
-
0031056372
-
EGFR and steroid receptors in ovarian carcinoma: Comparison with prognostic parameters and outcome of patients
-
Fischer-Colbrie J., Witt A., Heinzl H., Speiser P., Czerwenka K., Sevelda P., Zeillinger R. EGFR and steroid receptors in ovarian carcinoma: Comparison with prognostic parameters and outcome of patients. Anticancer Res. 17(1B):1997;613-619.
-
(1997)
Anticancer Res
, vol.17
, Issue.1 B
, pp. 613-619
-
-
Fischer-Colbrie, J.1
Witt, A.2
Heinzl, H.3
Speiser, P.4
Czerwenka, K.5
Sevelda, P.6
Zeillinger, R.7
-
28
-
-
0036118262
-
Epidermal growth factor receptor family in lung cancer and premalignancy
-
Franklin W.A., Veve R., Hirsch F.R., Helfrich B.A., Bunn P.A. Jr. Epidermal growth factor receptor family in lung cancer and premalignancy. Semin Oncol. 29(1 Suppl. 4):2002;3-14.
-
(2002)
Semin Oncol
, vol.29
, Issue.1 SUPPL. 4
, pp. 3-14
-
-
Franklin, W.A.1
Veve, R.2
Hirsch, F.R.3
Helfrich, B.A.4
Bunn, P.A.Jr.5
-
29
-
-
0030297662
-
A comparison of epidermal growth factor receptor levels and other prognostic parameters in non-small cell lung cancer
-
Fujino S., Enokibori T., Tezuka N., Asada Y., Inoue S., Kato H., Mori A. A comparison of epidermal growth factor receptor levels and other prognostic parameters in non-small cell lung cancer. Eur J Cancer. 32A(12):1996;2070-2074.
-
(1996)
Eur J Cancer
, vol.32
, Issue.12
, pp. 2070-2074
-
-
Fujino, S.1
Enokibori, T.2
Tezuka, N.3
Asada, Y.4
Inoue, S.5
Kato, H.6
Mori, A.7
-
30
-
-
0003336304
-
Final results from a phase II trial of ZD1839 ('Iressa') for patients with advanced non-small-cell lung cancer (IDEAL 1)
-
(Abstract No: 1188)
-
Fukuoka M., Yano S., Giaccone G., Tamura T., Nakagawa K., Douillard J., Nishiwaki Y., Vansteenkiste J.F., Kudo S., Averbuch S., Macleod A., Feyereislova A., Baselga J. Final results from a phase II trial of ZD1839 ('Iressa') for patients with advanced non-small-cell lung cancer (IDEAL 1). Proc Am Soc Clin Oncol. 21:2002;2989. (Abstract No: 1188).
-
(2002)
Proc Am Soc Clin Oncol
, vol.21
, pp. 2989
-
-
Fukuoka, M.1
Yano, S.2
Giaccone, G.3
Tamura, T.4
Nakagawa, K.5
Douillard, J.6
Nishiwaki, Y.7
Vansteenkiste, J.F.8
Kudo, S.9
Averbuch, S.10
MacLeod, A.11
Feyereislova, A.12
Baselga, J.13
-
31
-
-
0035799531
-
Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells
-
Garcia R., Bowman T.L., Niu G., Yu H., Minton S., Muro-Cacho C.A., Cox C.E., Falcone R., Fairclough R., Parsons S., Laudano A., Gazit A., Levitzki A., Kraker A., Jove R. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene. 20(20):2001;2499-2513.
-
(2001)
Oncogene
, vol.20
, Issue.20
, pp. 2499-2513
-
-
Garcia, R.1
Bowman, T.L.2
Niu, G.3
Yu, H.4
Minton, S.5
Muro-Cacho, C.A.6
Cox, C.E.7
Falcone, R.8
Fairclough, R.9
Parsons, S.10
Laudano, A.11
Gazit, A.12
Levitzki, A.13
Kraker, A.14
Jove, R.15
-
32
-
-
0028908255
-
Data quality assurance, monitoring, and reporting
-
Gassman J.J., Owen W.W., Kuntz T.E., Martin J.P., Amoroso W.P. Data quality assurance, monitoring, and reporting. Control Clin Trials. 16(2 Suppl.):1995;104S-136S.
-
(1995)
Control Clin Trials
, vol.16
, Issue.2 SUPPL.
-
-
Gassman, J.J.1
Owen, W.W.2
Kuntz, T.E.3
Martin, J.P.4
Amoroso, W.P.5
-
33
-
-
0002806626
-
A phase III clinical trial of ZD1839 ('Iressa') in combination with gemcitabine and cisplatin in chemotherapy-naive patients with advanced non-small-call lung cancer
-
(Abstract 40)
-
Giaccone G.A. A phase III clinical trial of ZD1839 ('Iressa') in combination with gemcitabine and cisplatin in chemotherapy-naive patients with advanced non-small-call lung cancer. Ann Oncol. 13:2002;2. (Abstract 40).
-
(2002)
Ann Oncol
, vol.13
, pp. 2
-
-
Giaccone, G.A.1
-
34
-
-
0001744237
-
Retinoic acid normalizes the increased gene transcription rate of TGF-alpha and EGFR in head and neck cancer cell lines
-
Grandis J.R., Zeng Q., Tweardy D.J. Retinoic acid normalizes the increased gene transcription rate of TGF-alpha and EGFR in head and neck cancer cell lines. Nat Med. 2(2):1996;237-240.
-
(1996)
Nat Med
, vol.2
, Issue.2
, pp. 237-240
-
-
Grandis, J.R.1
Zeng, Q.2
Tweardy, D.J.3
-
35
-
-
0013689209
-
Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth in vitro
-
Grandis J.R., Drenning S.D., Chakraborty A., Zhou M.Y., Zeng Q., Pitt A.S., Tweardy D.J. Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth in vitro. J Clin Invest. 102(7):1998;1385-1392.
-
(1998)
J Clin Invest
, vol.102
, Issue.7
, pp. 1385-1392
-
-
Grandis, J.R.1
Drenning, S.D.2
Chakraborty, A.3
Zhou, M.Y.4
Zeng, Q.5
Pitt, A.S.6
Tweardy, D.J.7
-
36
-
-
12944272024
-
Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo
-
Grandis J.R., Drenning S.D., Zeng Q., Watkins S.C., Melhem M.F., Endo S., Johnson D.E., Huang L., He Y., Kim J.D. Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc Natl Acad Sci USA. 97(8):2000;4227-4232.
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, Issue.8
, pp. 4227-4232
-
-
Grandis, J.R.1
Drenning, S.D.2
Zeng, Q.3
Watkins, S.C.4
Melhem, M.F.5
Endo, S.6
Johnson, D.E.7
Huang, L.8
He, Y.9
Kim, J.D.10
-
37
-
-
0038718522
-
Developing inhibitors of the epidermal growth factor receptor for cancer treatment
-
Grunwald V., Hidalgo M. Developing inhibitors of the epidermal growth factor receptor for cancer treatment. J Natl Cancer Inst. 95(12):2003;851-867.
-
(2003)
J Natl Cancer Inst
, vol.95
, Issue.12
, pp. 851-867
-
-
Grunwald, V.1
Hidalgo, M.2
-
38
-
-
0032528051
-
Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter
-
He Y., Zeng Q., Drenning S.D., Melhem M.F., Tweardy D.J., Huang L., Grandis J.R. Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter. J Natl Cancer Inst. 90(14):1998;1080-1087.
-
(1998)
J Natl Cancer Inst
, vol.90
, Issue.14
, pp. 1080-1087
-
-
He, Y.1
Zeng, Q.2
Drenning, S.D.3
Melhem, M.F.4
Tweardy, D.J.5
Huang, L.6
Grandis, J.R.7
-
39
-
-
0036124415
-
Epidermal growth factor receptors as a target for cancer treatment: The emerging role of IMC-C225 in the treatment of lung and head and neck cancers
-
Herbst R.S., Langer C.J. Epidermal growth factor receptors as a target for cancer treatment: The emerging role of IMC-C225 in the treatment of lung and head and neck cancers. Semin Oncol. 29(1 Suppl. 4):2002;27-36.
-
(2002)
Semin Oncol
, vol.29
, Issue.1 SUPPL. 4
, pp. 27-36
-
-
Herbst, R.S.1
Langer, C.J.2
-
40
-
-
0036500831
-
Monoclonal antibodies to target epidermal growth factor receptor-positive tumors: A new paradigm for cancer therapy
-
Herbst R.S., Shin D.M. Monoclonal antibodies to target epidermal growth factor receptor-positive tumors: a new paradigm for cancer therapy. Cancer. 94(5):2002;1593-1611.
-
(2002)
Cancer
, vol.94
, Issue.5
, pp. 1593-1611
-
-
Herbst, R.S.1
Shin, D.M.2
-
41
-
-
0002462661
-
Inhibition of the epidermal growth factor receptor (EGFR) by OSI-774, a specific EGFR inhibitor in malignant and normal tissues of cancer patients
-
(281)
-
Hidalgo M., Malik S., Rowinsky E.et al. Inhibition of the epidermal growth factor receptor (EGFR) by OSI-774, a specific EGFR inhibitor in malignant and normal tissues of cancer patients. Proc Am Soc Clin Oncol. 20:2001;71a. (281).
-
(2001)
Proc Am Soc Clin Oncol
, vol.20
-
-
Hidalgo, M.1
Malik, S.2
Rowinsky, E.3
-
42
-
-
0003282151
-
Phase 1 trial of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor (EGFR), in patients with advanced solid tumors
-
(Abstract 65)
-
Hidalgo M., Erlichman C., Rowinsky E.K., Koepp-Norris J., Jensen K., Boni J., Korth-Bradley J., Quinn S., Zacharchuk C. Phase 1 trial of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor (EGFR), in patients with advanced solid tumors. Proc Am Soc Clin Oncol. 21:2002;17a. (Abstract 65).
-
(2002)
Proc Am Soc Clin Oncol
, vol.21
-
-
Hidalgo, M.1
Erlichman, C.2
Rowinsky, E.K.3
Koepp-Norris, J.4
Jensen, K.5
Boni, J.6
Korth-Bradley, J.7
Quinn, S.8
Zacharchuk, C.9
-
43
-
-
0001100601
-
A phase I and pharmacological study of PKI166, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, administered orally in a two weeks on, two weeks off scheme to patients with advanced cancer
-
(Abstract # 340)
-
Hoekstra R., Dumez H., van Oosterom A.T., Sizer K.C., Ravera C., Vaidyanathan S., Verweij J., Eskens F.A. A phase I and pharmacological study of PKI166, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, administered orally in a two weeks on, two weeks off scheme to patients with advanced cancer. Proc Am Soc Clin Oncol. 21:2002;86a. (Abstract # 340).
-
(2002)
Proc Am Soc Clin Oncol
, vol.21
-
-
Hoekstra, R.1
Dumez, H.2
Van Oosterom, A.T.3
Sizer, K.C.4
Ravera, C.5
Vaidyanathan, S.6
Verweij, J.7
Eskens, F.A.8
-
44
-
-
0030499589
-
Overexpression of EGF receptor is associated with spontaneous metastases of a human melanoma cell line in nude mice
-
Huang T.S., Rauth S., Das Gupta T.K. Overexpression of EGF receptor is associated with spontaneous metastases of a human melanoma cell line in nude mice. Anticancer Res. 16(6B):1996;3557-3563.
-
(1996)
Anticancer Res
, vol.16
, Issue.6 B
, pp. 3557-3563
-
-
Huang, T.S.1
Rauth, S.2
Das Gupta, T.K.3
-
45
-
-
0000780450
-
('Iressa') in combination with paclitaxel and carboplatin in chemotherapy-naive patients with advanced non-small-cell lung cancer (NSCLC) results from a phase III clinical trial
-
(Abstract 4680)
-
Johnson D.H. ('Iressa') in combination with paclitaxel and carboplatin in chemotherapy-naive patients with advanced non-small-cell lung cancer (NSCLC) results from a phase III clinical trial. Ann Oncol. 13:2002;127. (Abstract 4680).
-
(2002)
Ann Oncol
, vol.13
, pp. 127
-
-
Johnson, D.H.1
-
46
-
-
0033009389
-
Binding specificities and affinities of egf domains for ErbB receptors
-
Jones J.T., Akita R.W., Sliwkowski M.X. Binding specificities and affinities of egf domains for ErbB receptors. FEBS Lett. 447(2-3):1999;227-231.
-
(1999)
FEBS Lett
, vol.447
, Issue.23
, pp. 227-231
-
-
Jones, J.T.1
Akita, R.W.2
Sliwkowski, M.X.3
-
47
-
-
0026571910
-
The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: A review on 5232 patients
-
Klijn J.G., Berns P.M., Schmitz P.I., Foekens J.A. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: A review on 5232 patients. Endocr Rev. 13(1):1992;3-17.
-
(1992)
Endocr Rev
, vol.13
, Issue.1
, pp. 3-17
-
-
Klijn, J.G.1
Berns, P.M.2
Schmitz, P.I.3
Foekens, J.A.4
-
48
-
-
0031466502
-
Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4
-
Komurasaki T., Toyoda H., Uchida D., Morimoto S. Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4. Oncogene. 15(23):1997;2841-2848.
-
(1997)
Oncogene
, vol.15
, Issue.23
, pp. 2841-2848
-
-
Komurasaki, T.1
Toyoda, H.2
Uchida, D.3
Morimoto, S.4
-
49
-
-
0001303063
-
A phase II trial of ZD1839 ('Iressa') in advanced non-small cell lung cancer (NSCLC) patients who had failed platinum- and docetaxel-based regimens (IDEAL 2)
-
(Abstract 1166)
-
Kris M.G., Natale R.B., Herbst R.S., Lynch T.J. Jr., Prager D., Belani C.P., Schiller J.H., Kelly K., Spiridonidis C., Albain K.S., Brahmer J.R., Sandler A., Crawford J., Lutzker S.G., Lilenbaum R., Helms L., Wolf M., Averbuch S., Ochs J., Kay A. A phase II trial of ZD1839 ('Iressa') in advanced non-small cell lung cancer (NSCLC) patients who had failed platinum- and docetaxel-based regimens (IDEAL 2). Proc Am Soc Clin Oncol. 21:2002;2929. (Abstract 1166).
-
(2002)
Proc Am Soc Clin Oncol
, vol.21
, pp. 2929
-
-
Kris, M.G.1
Natale, R.B.2
Herbst, R.S.3
Lynch, T.J.Jr.4
Prager, D.5
Belani, C.P.6
Schiller, J.H.7
Kelly, K.8
Spiridonidis, C.9
Albain, K.S.10
Brahmer, J.R.11
Sandler, A.12
Crawford, J.13
Lutzker, S.G.14
Lilenbaum, R.15
Helms, L.16
Wolf, M.17
Averbuch, S.18
Ochs, J.19
Kay, A.20
more..
-
50
-
-
0031858266
-
The localization of transforming growth factor alpha and epidermal growth factor receptor in stromal and epithelial compartments of developing human prostate and hyperplastic, dysplastic, and carcinomatous lesions
-
Leav I., McNeal J.E., Ziar J., Alroy J. The localization of transforming growth factor alpha and epidermal growth factor receptor in stromal and epithelial compartments of developing human prostate and hyperplastic, dysplastic, and carcinomatous lesions. Hum Pathol. 29(7):1998;668-675.
-
(1998)
Hum Pathol
, vol.29
, Issue.7
, pp. 668-675
-
-
Leav, I.1
McNeal, J.E.2
Ziar, J.3
Alroy, J.4
-
51
-
-
0028858730
-
Overexpression of phospholipase C-gamma 1 in colorectal carcinomas is associated with overexpression of factors that bind its promoter
-
Lee S.J., Lee S.D., Park J.G., Kim C.M., Ryu S.H., Suh P.G. Overexpression of phospholipase C-gamma 1 in colorectal carcinomas is associated with overexpression of factors that bind its promoter. J Biol Chem. 270(27):1995;16378-16384.
-
(1995)
J Biol Chem
, vol.270
, Issue.27
, pp. 16378-16384
-
-
Lee, S.J.1
Lee, S.D.2
Park, J.G.3
Kim, C.M.4
Ryu, S.H.5
Suh, P.G.6
-
52
-
-
0027987263
-
Autophosphorylation mutants of the EGF-receptor signal through auxiliary mechanisms involving SH2 domain proteins
-
Li N., Schlessinger J., Margolis B. Autophosphorylation mutants of the EGF-receptor signal through auxiliary mechanisms involving SH2 domain proteins. Oncogene. 9(12):1994;3457-3465.
-
(1994)
Oncogene
, vol.9
, Issue.12
, pp. 3457-3465
-
-
Li, N.1
Schlessinger, J.2
Margolis, B.3
-
53
-
-
0037044783
-
Transactivation of the epidermal growth factor receptor in colonic epithelial cells by carbachol requires extracellular release of transforming growth factor-alpha
-
McCole D.F., Keely S.J., Coffey R.J., Barrett K.E. Transactivation of the epidermal growth factor receptor in colonic epithelial cells by carbachol requires extracellular release of transforming growth factor-alpha. J Biol Chem. 277(45):2002;42603-42612.
-
(2002)
J Biol Chem
, vol.277
, Issue.45
, pp. 42603-42612
-
-
McCole, D.F.1
Keely, S.J.2
Coffey, R.J.3
Barrett, K.E.4
-
54
-
-
0031800885
-
EGF, TGF-alpha, and EGF-R in human colorectal adenocarcinoma
-
Messa C., Russo F., Caruso M.G., Di Leo A. EGF, TGF-alpha, and EGF-R in human colorectal adenocarcinoma. Acta Oncol. 37(3):1998;285-289.
-
(1998)
Acta Oncol
, vol.37
, Issue.3
, pp. 285-289
-
-
Messa, C.1
Russo, F.2
Caruso, M.G.3
Di Leo, A.4
-
55
-
-
0027732568
-
New Gaba-containing analogues of human growth hormone-releasing hormone (1-30)-amide: I. Synthesis and in vitro biological activity
-
Mezo I., Kovacs M., Szoke B., Szabo E.Z., Horvath J., Makara G.B., Rappay G., Tamas J., Teplan I. New Gaba-containing analogues of human growth hormone-releasing hormone (1-30)-amide: I. Synthesis and in vitro biological activity. J Endocrinol Invest. 16(10):1993;793-798.
-
(1993)
J Endocrinol Invest
, vol.16
, Issue.10
, pp. 793-798
-
-
Mezo, I.1
Kovacs, M.2
Szoke, B.3
Szabo, E.Z.4
Horvath, J.5
Makara, G.B.6
Rappay, G.7
Tamas, J.8
Teplan, I.9
-
56
-
-
0029074587
-
Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor
-
Miettinen P.J., Berger J.E., Meneses J., Phung Y., Pedersen R.A., Werb Z., Derynck R. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature. 376(6538):1995;337-341.
-
(1995)
Nature
, vol.376
, Issue.6538
, pp. 337-341
-
-
Miettinen, P.J.1
Berger, J.E.2
Meneses, J.3
Phung, Y.4
Pedersen, R.A.5
Werb, Z.6
Derynck, R.7
-
57
-
-
0029063936
-
The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor
-
Miller W.E., Earp H.S., Raab-Traub N. The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. J Virol. 69(7):1995;4390-4398.
-
(1995)
J Virol
, vol.69
, Issue.7
, pp. 4390-4398
-
-
Miller, W.E.1
Earp, H.S.2
Raab-Traub, N.3
-
58
-
-
0028800035
-
Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors
-
Moscatello D.K., Holgado-Madruga M., Godwin A.K., Ramirez G., Gunn G., Zoltick P.W., Biegel J.A., Hayes R.L., Wong A.J. Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors. Cancer Res. 55(23):1995;5536-5539.
-
(1995)
Cancer Res
, vol.55
, Issue.23
, pp. 5536-5539
-
-
Moscatello, D.K.1
Holgado-Madruga, M.2
Godwin, A.K.3
Ramirez, G.4
Gunn, G.5
Zoltick, P.W.6
Biegel, J.A.7
Hayes, R.L.8
Wong, A.J.9
-
59
-
-
0029666423
-
Transformational and altered signal transduction by a naturally occurring mutant EGF receptor
-
Moscatello D.K., Montgomery R.B., Sundareshan P., McDanel H., Wong M.Y., Wong A.J. Transformational and altered signal transduction by a naturally occurring mutant EGF receptor. Oncogene. 13(1):1996;85-96.
-
(1996)
Oncogene
, vol.13
, Issue.1
, pp. 85-96
-
-
Moscatello, D.K.1
Montgomery, R.B.2
Sundareshan, P.3
McDanel, H.4
Wong, M.Y.5
Wong, A.J.6
-
60
-
-
0031961980
-
Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor
-
Moscatello D.K., Holgado-Madruga M., Emlet D.R., Montgomery R.B., Wong A.J. Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor. J Biol Chem. 273(1):1998;200-206.
-
(1998)
J Biol Chem
, vol.273
, Issue.1
, pp. 200-206
-
-
Moscatello, D.K.1
Holgado-Madruga, M.2
Emlet, D.R.3
Montgomery, R.B.4
Wong, A.J.5
-
61
-
-
0001100596
-
A phase I dose-escalating study to evaluate the biological activity and pharmacokinetics of PKI166, a novel tyrosine kinase inhibitor, in patients with advanced cancers
-
Abstract 377.
-
Murren, J. R., Papadimitrakopoulou, V., Sizer, K.C., Vaidyanathan, S., Ravera, C., & Abbruzzese, J.L. (2002). A phase I dose-escalating study to evaluate the biological activity and pharmacokinetics of PKI166, a novel tyrosine kinase inhibitor, in patients with advanced cancers. Paper presented at the Proceedings American Society of Clinical Oncology, Abstract 377.
-
(2002)
Paper presented at the Proceedings American Society of Clinical Oncology
-
-
Murren, J.R.1
Papadimitrakopoulou, V.2
Sizer, K.C.3
Vaidyanathan, S.4
Ravera, C.5
Abbruzzese, J.L.6
-
62
-
-
0034833599
-
Quantitation of epidermal growth factor receptor gene amplification by competitive polymerase chain reaction in pre-malignant and malignant oral epithelial lesions
-
Nagatsuka H., Ishiwari Y., Tsujigiwa H., Nakano K., Nagai N. Quantitation of epidermal growth factor receptor gene amplification by competitive polymerase chain reaction in pre-malignant and malignant oral epithelial lesions. Oral Oncol. 37(7):2001;599-604.
-
(2001)
Oral Oncol
, vol.37
, Issue.7
, pp. 599-604
-
-
Nagatsuka, H.1
Ishiwari, Y.2
Tsujigiwa, H.3
Nakano, K.4
Nagai, N.5
-
63
-
-
0037112423
-
Mutant epidermal growth factor receptor signaling down-regulates p27 through activation of the phosphatidylinositol 3-kinase/Akt pathway in glioblastomas
-
Narita Y., Nagane M., Mishima K., Huang H.J., Furnari F.B., Cavenee W.K. Mutant epidermal growth factor receptor signaling down-regulates p27 through activation of the phosphatidylinositol 3-kinase/Akt pathway in glioblastomas. Cancer Res. 62(22):2002;6764-6769.
-
(2002)
Cancer Res
, vol.62
, Issue.22
, pp. 6764-6769
-
-
Narita, Y.1
Nagane, M.2
Mishima, K.3
Huang, H.J.4
Furnari, F.B.5
Cavenee, W.K.6
-
64
-
-
0035282696
-
Fluorescent RNA cytochemistry: Tracking gene transcripts in living cells
-
Pederson T. Fluorescent RNA cytochemistry: Tracking gene transcripts in living cells. Nucleic Acids Res. 29(5):2001;1013-1016.
-
(2001)
Nucleic Acids Res
, vol.29
, Issue.5
, pp. 1013-1016
-
-
Pederson, T.1
-
65
-
-
0031037444
-
4.5-Mb YAC STS contig at 50-kb resolution, spanning Xq25 deletions in two patients with lymphoproliferative syndrome
-
Porta G., MacMillan S., Nagaraja R., Mumm S., Zucchi I., Pilia G., Maio S., Featherstone T., Schlessinger D. 4.5-Mb YAC STS contig at 50-kb resolution, spanning Xq25 deletions in two patients with lymphoproliferative syndrome. Genome Res. 7(1):1997;27-36.
-
(1997)
Genome Res
, vol.7
, Issue.1
, pp. 27-36
-
-
Porta, G.1
MacMillan, S.2
Nagaraja, R.3
Mumm, S.4
Zucchi, I.5
Pilia, G.6
Maio, S.7
Featherstone, T.8
Schlessinger, D.9
-
66
-
-
0029815093
-
Enhanced tumorigenic behavior of glioblastoma cells expressing a truncated epidermal growth factor receptor is mediated through the Ras-Shc-Grb2 pathway
-
Prigent S.A., Nagane M., Lin H., Huvar I., Boss G.R., Feramisco J.R., Cavenee W.K., Huang H.S. Enhanced tumorigenic behavior of glioblastoma cells expressing a truncated epidermal growth factor receptor is mediated through the Ras-Shc-Grb2 pathway. J Biol Chem. 271(41):1996;25639-25645.
-
(1996)
J Biol Chem
, vol.271
, Issue.41
, pp. 25639-25645
-
-
Prigent, S.A.1
Nagane, M.2
Lin, H.3
Huvar, I.4
Boss, G.R.5
Feramisco, J.R.6
Cavenee, W.K.7
Huang, H.S.8
-
67
-
-
0031936410
-
Specificity within the EGF family/ErbB receptor family signaling network
-
Riese D.J. II, Stern D.F. Specificity within the EGF family/ErbB receptor family signaling network. BioEssays. 20(1):1998;41-48.
-
(1998)
BioEssays
, vol.20
, Issue.1
, pp. 41-48
-
-
Riese II, D.J.1
Stern, D.F.2
-
68
-
-
0031657830
-
A comparative study of epidermal growth factor receptor (EGFR) and MDM2 gene amplification and protein immunoreactivity in human glioblastomas
-
Rieske P., Kordek R., Bartkowiak J., Debiec-Rychter M., Biernat W., Liberski P.P. A comparative study of epidermal growth factor receptor (EGFR) and MDM2 gene amplification and protein immunoreactivity in human glioblastomas. Pol J Pathol. 49(3):1998;145-149.
-
(1998)
Pol J Pathol
, vol.49
, Issue.3
, pp. 145-149
-
-
Rieske, P.1
Kordek, R.2
Bartkowiak, J.3
Debiec-Rychter, M.4
Biernat, W.5
Liberski, P.P.6
-
69
-
-
0030685807
-
Severe neuropathies in mice with targeted mutations in the ErbB3 receptor
-
Riethmacher D., Sonnenberg-Riethmacher E., Brinkmann V., Yamaai T., Lewin G.R., Birchmeier C. Severe neuropathies in mice with targeted mutations in the ErbB3 receptor. Nature. 389(6652):1997;725-730.
-
(1997)
Nature
, vol.389
, Issue.6652
, pp. 725-730
-
-
Riethmacher, D.1
Sonnenberg-Riethmacher, E.2
Brinkmann, V.3
Yamaai, T.4
Lewin, G.R.5
Birchmeier, C.6
-
70
-
-
0035398021
-
Phase I study of anti-epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer
-
Robert F., Ezekiel M.P., Spencer S.A., Meredith R.F., Bonner J.A., Khazaeli M.B., Saleh M.N., Carey D., LoBuglio A.F., Wheeler R.H., Cooper M.R., Waksal H.W. Phase I study of anti-epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer. J Clin Oncol. 19(13):2001;3234-3243.
-
(2001)
J Clin Oncol
, vol.19
, Issue.13
, pp. 3234-3243
-
-
Robert, F.1
Ezekiel, M.P.2
Spencer, S.A.3
Meredith, R.F.4
Bonner, J.A.5
Khazaeli, M.B.6
Saleh, M.N.7
Carey, D.8
Lobuglio, A.F.9
Wheeler, R.H.10
Cooper, M.R.11
Waksal, H.W.12
-
71
-
-
0001744237
-
Retinoic acid normalizes the increased gene transcription rate of TGF-alpha and EGFR in head and neck cancer cell lines
-
Rubin Grandis J., Zeng Q., Tweardy D.J. Retinoic acid normalizes the increased gene transcription rate of TGF-alpha and EGFR in head and neck cancer cell lines. Nat Med. 2(2):1996;237-240.
-
(1996)
Nat Med
, vol.2
, Issue.2
, pp. 237-240
-
-
Rubin Grandis, J.1
Zeng, Q.2
Tweardy, D.J.3
-
72
-
-
0029831041
-
Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck
-
Rubin Grandis J., Melhem M.F., Barnes E.L., Tweardy D.J. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck. Cancer. 78(6):1996;1284-1292.
-
(1996)
Cancer
, vol.78
, Issue.6
, pp. 1284-1292
-
-
Rubin Grandis, J.1
Melhem, M.F.2
Barnes, E.L.3
Tweardy, D.J.4
-
73
-
-
0030757686
-
Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells
-
Rubin Grandis J., Chakraborty A., Melhem M.F., Zeng Q., Tweardy D.J. Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells. Oncogene. 15(4):1997;409-416.
-
(1997)
Oncogene
, vol.15
, Issue.4
, pp. 409-416
-
-
Rubin Grandis, J.1
Chakraborty, A.2
Melhem, M.F.3
Zeng, Q.4
Tweardy, D.J.5
-
74
-
-
0013650320
-
Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma
-
Rubin Grandis J., Tweardy D.J., Melhem M.F. Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma. Clin Cancer Res. 4(1):1998;13-20.
-
(1998)
Clin Cancer Res
, vol.4
, Issue.1
, pp. 13-20
-
-
Rubin Grandis, J.1
Tweardy, D.J.2
Melhem, M.F.3
-
75
-
-
0032478998
-
Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival
-
[see comments]
-
Rubin Grandis J., Melhem M.F., Gooding W.E., Day R., Holst V.A., Wagener M.M., Drenning S.D., Tweardy D.J. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. [see comments] J Natl Cancer Inst. 90(11):1998;824-832.
-
(1998)
J Natl Cancer Inst
, vol.90
, Issue.11
, pp. 824-832
-
-
Rubin Grandis, J.1
Melhem, M.F.2
Gooding, W.E.3
Day, R.4
Holst, V.A.5
Wagener, M.M.6
Drenning, S.D.7
Tweardy, D.J.8
-
76
-
-
0030980781
-
Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression
-
Rusch V., Klimstra D., Venkatraman E., Pisters P.W., Langenfeld J., Dmitrovsky E. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression. Clin Cancer Res. 3(4):1997;515-522.
-
(1997)
Clin Cancer Res
, vol.3
, Issue.4
, pp. 515-522
-
-
Rusch, V.1
Klimstra, D.2
Venkatraman, E.3
Pisters, P.W.4
Langenfeld, J.5
Dmitrovsky, E.6
-
77
-
-
0028955388
-
Epidermal growth factor-related peptides and their receptors in human malignancies
-
Salomon D.S. Epidermal growth factor-related peptides and their receptors in human malignancies. Oncol Hematol. 19:1995;183-232.
-
(1995)
Oncol Hematol
, vol.19
, pp. 183-232
-
-
Salomon, D.S.1
-
78
-
-
0026793456
-
Growth factor signaling by receptor tyrosine kinases
-
Schlessinger J., Ullrich A. Growth factor signaling by receptor tyrosine kinases. Neuron. 9(3):1992;383-391.
-
(1992)
Neuron
, vol.9
, Issue.3
, pp. 383-391
-
-
Schlessinger, J.1
Ullrich, A.2
-
79
-
-
0031005779
-
A thousand and one roles for the Drosophila EGF receptor
-
Schweitzer R., Shilo B.Z. A thousand and one roles for the Drosophila EGF receptor. Trends Genet. 13(5):1997;191-196.
-
(1997)
Trends Genet
, vol.13
, Issue.5
, pp. 191-196
-
-
Schweitzer, R.1
Shilo, B.Z.2
-
80
-
-
0034895886
-
Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer
-
Shin D.M., Donato N.J., Perez-Soler R., Shin H.J., Wu J.Y., Zhang P., Lawhorn K., Khuri F.R., Glisson B.S., Myers J., Clayman G., Pfister D., Falcey J., Waksal H., Mendelsohn J., Hong W.K. Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer. Clin Cancer Res. 7(5):2001;1204-1213.
-
(2001)
Clin Cancer Res
, vol.7
, Issue.5
, pp. 1204-1213
-
-
Shin, D.M.1
Donato, N.J.2
Perez-Soler, R.3
Shin, H.J.4
Wu, J.Y.5
Zhang, P.6
Lawhorn, K.7
Khuri, F.R.8
Glisson, B.S.9
Myers, J.10
Clayman, G.11
Pfister, D.12
Falcey, J.13
Waksal, H.14
Mendelsohn, J.15
Hong, W.K.16
-
81
-
-
0035168761
-
CI-1033, a pan-erbB tyrosine kinase inhibitor
-
Slichenmyer W.J., Elliott W.L., Fry D.W. CI-1033, a pan-erbB tyrosine kinase inhibitor. Semin Oncol. 28(5 Suppl. 16):2001;80-85.
-
(2001)
Semin Oncol
, vol.28
, Issue.5 SUPPL. 16
, pp. 80-85
-
-
Slichenmyer, W.J.1
Elliott, W.L.2
Fry, D.W.3
-
82
-
-
0035205190
-
Evaluation of TGF-alpha and EGFR expression in oral leukoplakia and oral submucous fibrosis by quantitative immunohistochemistry
-
Srinivasan M., Jewell S.D. Evaluation of TGF-alpha and EGFR expression in oral leukoplakia and oral submucous fibrosis by quantitative immunohistochemistry. Oncology. 61(4):2001;284-292.
-
(2001)
Oncology
, vol.61
, Issue.4
, pp. 284-292
-
-
Srinivasan, M.1
Jewell, S.D.2
-
83
-
-
0031452314
-
Clinicopathological significance of epidermal growth factor and its receptor in human pancreatic cancer
-
Uegaki K., Nio Y., Inoue Y., Minari Y., Sato Y., Song M.M., Dong M., Tamura K. Clinicopathological significance of epidermal growth factor and its receptor in human pancreatic cancer. Anticancer Res. 17(5B):1997;3841-3847.
-
(1997)
Anticancer Res
, vol.17
, Issue.5 B
, pp. 3841-3847
-
-
Uegaki, K.1
Nio, Y.2
Inoue, Y.3
Minari, Y.4
Sato, Y.5
Song, M.M.6
Dong, M.7
Tamura, K.8
-
84
-
-
0026955947
-
Expression of epidermal growth factor receptor and ERBB2 (HER-2/Neu) oncoprotein in prostatic carcinomas
-
Visakorpi T., Kallioniemi O.P., Koivula T., Harvey J., Isola J. Expression of epidermal growth factor receptor and ERBB2 (HER-2/Neu) oncoprotein in prostatic carcinomas. Mod Pathol. 5(6):1992;643-648.
-
(1992)
Mod Pathol
, vol.5
, Issue.6
, pp. 643-648
-
-
Visakorpi, T.1
Kallioniemi, O.P.2
Koivula, T.3
Harvey, J.4
Isola, J.5
-
85
-
-
0032927489
-
Expression of epidermal growth factor receptor mRNA and protein in primary breast carcinomas
-
Walker R.A., Dearing S.J. Expression of epidermal growth factor receptor mRNA and protein in primary breast carcinomas. Breast Cancer Res Treat. 53(2):1999;167-176.
-
(1999)
Breast Cancer Res Treat
, vol.53
, Issue.2
, pp. 167-176
-
-
Walker, R.A.1
Dearing, S.J.2
-
86
-
-
0033369780
-
Aberrations of erbB-1 and erbB-2 oncogenes in non-dysplastic leukoplakias of the oral cavity
-
Werkmeister R., Brandt B., Joos U. Aberrations of erbB-1 and erbB-2 oncogenes in non-dysplastic leukoplakias of the oral cavity. Br J Oral Maxillofac Surg. 37(6):1999;477-480.
-
(1999)
Br J Oral Maxillofac Surg
, vol.37
, Issue.6
, pp. 477-480
-
-
Werkmeister, R.1
Brandt, B.2
Joos, U.3
-
87
-
-
0029025332
-
Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas
-
Wikstrand C.J., Hale L.P., Batra S.K., Hill M.L., Humphrey P.A., Kurpad S.N., McLendon R.E., Moscatello D., Pegram C.N., Reist C.J.et al. Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. Cancer Res. 55(14):1995;3140-3148.
-
(1995)
Cancer Res
, vol.55
, Issue.14
, pp. 3140-3148
-
-
Wikstrand, C.J.1
Hale, L.P.2
Batra, S.K.3
Hill, M.L.4
Humphrey, P.A.5
Kurpad, S.N.6
McLendon, R.E.7
Moscatello, D.8
Pegram, C.N.9
Reist, C.J.10
-
88
-
-
0030832167
-
Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII
-
Wikstrand C.J., McLendon R.E., Friedman A.H., Bigner D.D. Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII. Cancer Res. 57(18):1997;4130-4140.
-
(1997)
Cancer Res
, vol.57
, Issue.18
, pp. 4130-4140
-
-
Wikstrand, C.J.1
McLendon, R.E.2
Friedman, A.H.3
Bigner, D.D.4
-
89
-
-
0026548240
-
Structural alterations of the epidermal growth factor receptor gene in human gliomas
-
Wong A.J., Ruppert J.M., Bigner S.H., Grzeschik C.H., Humphrey P.A., Bigner D.S., Vogelstein B. Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc Natl Acad Sci USA. 89(7):1992;2965-2969.
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, Issue.7
, pp. 2965-2969
-
-
Wong, A.J.1
Ruppert, J.M.2
Bigner, S.H.3
Grzeschik, C.H.4
Humphrey, P.A.5
Bigner, D.S.6
Vogelstein, B.7
-
90
-
-
0030936677
-
Studies of the expression of epidermal growth factor receptor in human renal cell carcinoma: A comparison of immunohistochemical method versus ligand binding assay
-
Yoshida K., Hosoya Y., Sumi S., Honda M., Moriguchi H., Yano M., Ueda Y. Studies of the expression of epidermal growth factor receptor in human renal cell carcinoma: a comparison of immunohistochemical method versus ligand binding assay. Oncology. 54(3):1997;220-225.
-
(1997)
Oncology
, vol.54
, Issue.3
, pp. 220-225
-
-
Yoshida, K.1
Hosoya, Y.2
Sumi, S.3
Honda, M.4
Moriguchi, H.5
Yano, M.6
Ueda, Y.7
|